This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Alembic Limited. Active years: 2007-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2011
Title: Hetal Remeshchandra Shah: Innovator in Pharmaceutical Chemistry
Introduction
Hetal Remeshchandra Shah is a prominent inventor based in Vadodara, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 3 patents to her name, her work has garnered attention in the industry.
Latest Patents
One of her latest patents is focused on a process for preparing Valsartan. This invention relates to a novel compound of formula (IV), which is an organic acid salt of N-[(2'-cyanobiphenyl-4-yl)methyl]-(L)-valine ester. This compound serves as a useful intermediate for the preparation of Valsartan, chemically known as (S)-N-(1-Carboxy-2-methylprop-1-yl)-N-pentanoyl-N-[2′-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]amine. The invention also outlines a process for preparing Valsartan using this novel intermediate.
Career Highlights
Hetal is currently employed at Alembic Limited, a well-known pharmaceutical company. Her work at Alembic has allowed her to focus on innovative solutions in drug development and formulation. She has established herself as a key player in her field, contributing to advancements that benefit healthcare.
Collaborations
Throughout her career, Hetal has collaborated with several talented individuals, including Rohit Ravikant Soni and Sanjay Lakhabhai Vasoya. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Hetal Remeshchandra Shah is a remarkable inventor whose work in pharmaceutical chemistry continues to impact the industry positively. Her dedication to innovation and collaboration exemplifies the spirit of advancement in science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
